Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

Publications des scientifiques de l'IRD

Charrel R., Mogling R., Pas S., Papa A., Baronti Cécile, Koopmans M., Zeller H., Leparc-Goffart I., Reusken C. B. (2017). Variable sensitivity in molecular detection of Zika virus in European expert laboratories : external quality assessment, november 2016. Journal of Clinical Microbiology, 55 (11), 3219-3226. ISSN 0095-1137

Accès réservé (Intranet IRD) Document en accès réservé (Intranet IRD)

Lien direct chez l'éditeur doi:10.1128/jcm.00987-17

Titre
Variable sensitivity in molecular detection of Zika virus in European expert laboratories : external quality assessment, november 2016
Année de publication2017
Type de documentArticle référencé dans le Web of Science WOS:000414356400012
AuteursCharrel R., Mogling R., Pas S., Papa A., Baronti Cécile, Koopmans M., Zeller H., Leparc-Goffart I., Reusken C. B.
SourceJournal of Clinical Microbiology, 2017, 55 (11), p. 3219-3226. ISSN 0095-1137
RésuméZika virus (ZIKV) infections are a significant public health concern. A strong capability for ZIKV detection is an absolute requirement for adequate preparedness and response strategies and individual patient care. The objective of this study was to assess and improve the capability of European expert laboratories for molecular testing for ZIKV through an external quality assessment (EQA) scheme. Laboratories were provided a panel of 12 samples which included negative samples, samples containing African-or Asian-lineage ZIKV at various concentrations (10(3) to 10(9) copies/ml), and samples containing dengue virus, yellow fever virus, or chikungunya virus. The results were analyzed on the basis of the outcomes of testing for the samples and the extraction and detection method used. Samples with a ZIKV RNA status scored correctly by >50% of the laboratories were designated the core sample. A total of 85 panel outcomes were submitted by 50 laboratories in 31 countries. The results designated all samples as core samples. Thirty-three percent (28/85) of the panel outcomes identified all samples. Analysis at the laboratory level showed that only 40% of the laboratories (20/50), representing 45% of the countries, scored sufficiently; i.e., they had at least one test operational that scored all core samples correctly. There is a need for improvement of the molecular detection of ZIKV in 60% of the participating laboratories. While the specificity of the tests was more robust, the results of the EQA showed large variation in test sensitivity. Improvements should focus on both nucleic acid extraction and ZIKV detection methods.
Plan de classementEntomologie médicale / Parasitologie / Virologie [052] ; Sciences fondamentales / Techniques d'analyse et de recherche [020]
Descr. géo.EUROPE
LocalisationFonds IRD [F B010071339]
Identifiant IRDfdi:010071339
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010071339

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Nouméa

Papeete

Niamey

Ouagadougou

Tunis

La Paz

Quito